Showing results 1 to 2 of 2
Issue Date | Title | Author(s) | Type |
---|---|---|---|
2024 | IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma | 정세운 | Article |
2022 | The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS | 배승진 | Article |